- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
ISRN Analytical Chemistry
Volume 2013 (2013), Article ID 534763, 8 pages
Method Development and Validation for Estimation of Eperisone Hydrochloride as API and in Tablet Dosage Form by Two Spectroscopic Methods
Department of Quality Assurance, Lachoo Memorial College of Science & Technology (Autonomous), Jodhpur, Rajasthan 342003, India
Received 24 July 2013; Accepted 12 August 2013
Academic Editors: A. Garcia Asuero, S. Göktürk, A. Niazi, and A. Szemik-Hojniak
Copyright © 2013 Joytosh Banerjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Two simple and sensitive spectrophotometric methods have been developed for the determination of eperisone hydrochloride based on its ability to be detected in UV region (Normal UV) and its oxidation using potassium permanganate in alkaline medium (kinetic spectroscopic). The detection was done at 261.40 nm and 603.5 nm. The different experimental parameters affecting the method development were studied and optimized. The initial rate and fixed time method were utilized to construct calibration graph, and 5 minutes and 3 minutes, respectively, were found suitable for the determination of the concentration of drug. Linearity was found over the concentration range of 2–20 μg/mL, 15–30 μg/mL, and 15–35 μg/mL by UV, initial rate, and fixed time methods, respectively. The results were validated as per the ICH guidelines. RSD values were found to be less than 2%. The methods were applied for estimation of eperisone hydrochloride in RAPISONE (Abbott, Maharashtra). The assay results were found to be 100.4% ± 0.08, 99.93% ± 0.05, and 99.41% ± 0.04 by UV, initial rate, and fixed time method, respectively. Statistical comparison of the proposed methods showed a good agreement indicating no significant difference in accuracy and precision, thus confirming the suitability of UV and kinetic method for the estimation of eperisone hydrochloride in bulk as well as in tablet dosage forms.
Eperisone hydrochloride is an antispasmodic drug sold in Japan, India, Philippines, and Bangladesh . It belongs to piperidinopropiophenone analogues, and its structure is shown in Figure 1. It acts by relaxing both skeletal muscles and vascular smooth muscles and demonstrates reduction of myotonia, improvement of circulation, and suppression of pain reflex . Kinetic spectrophotometric methods have regained interest in the recent past due to its specific advantages as well as improved capabilities of the modern instrument [3–5]. LC-ESI-MS , GC-MS [7, 8], and HPLC [9, 10] methods were proposed for the determination of eperisone hydrochloride in biological fluids. Various methods were proposed for the estimation of degradation products . Japanese Pharmacopeia reports potentiometric method for its estimation . Kinetic spectrophotometric method has not been reported so far in any literature. The objective of the research is to develop and validate UV and kinetic spectrophotometric method for the estimation of eperisone hydrochloride for routine analysis in bulk and tablet dosage forms. The methods would be statistically compared for their suitability for estimation of the drug.
2. Material and Method
Double distilled water was used as solvent to prepare solutions. Potassium permanganate (KMnO4) (LOBA CHEMIE, India) was accurately weighed and dissolved in distilled water to obtain a solution of 6 × 10−3 M as given in the Indian Pharmacopoeia (I.P.). Sodium hydroxide (NaOH) (LOBA CHEMIE, India) was also accurately weighed and dissolved in distilled water to obtain a solution of 1.0 M in distilled water. Shimadzu UV-1800 model with spectral band width one nm and wavelength accuracy of 0.3 nm was used for spectral measurements. One cm matched quartz cells were used for carrying the analyte solution. Weighing was done on electronic balance (GR-200, A & D Company). Glassware used in each procedure were washed and dried at the end of each day’s work. Pure drug of eperisone hydrochloride was obtained as gift sample from Sun Pharma Industries, Mumbai. Tablets of brand name RAPISONE (Batch no. AME-008B), marketed by Abbott, Maharashtra, were procured from local pharmacy.
2.1. Preparation of Standard Stock Solution
2.1.1. For Normal UV Spectrophotometric Method
Standard stock solution of 1000 μg/mL was prepared by dissolving 100 mg of pure active pharmaceutical ingredient in 100 mL of double distilled water in a volumetric flask.
2.1.2. For Kinetic Spectrophotometric Method
Stock solution A (for method development): 100 mg of eperisone hydrochloride was accurately weighed and transferred to 100 mL volumetric flask. It was dissolved in 25 mL of doubly distilled water, and the volume was made up to 100 mL with the same. The final solution contained 1000 μg/mL of eperisone hydrochloride solution.
Stock solution B (for determination of stoichiometry): 177.5 mg of eperisone hydrochloride was accurately weighed and transferred to 10 mL volumetric flask. It was dissolved in doubly distilled water, and the volume was made up to 10 mL with the same. The final solution contained 17750 μg/mL of eperisone hydrochloride solution.
2.2. Preparation of Sample Solution of Pharmaceutical Tablets
2.2.1. For Normal UV Method
Twenty tablets were taken, and the I.P. method was followed to determine the average weight. Weighed tablets were triturated well. A quantity of powder equivalent to 10 mg of drug was transferred to 100 mL volumetric flask and mixed with 25 mL of doubly distilled water. The solution was sonicated for 10 minutes, and the volume was made up to the mark with doubly distilled water solvent. The solution was then filtered through Whatman filter paper no. 42.
2.2.2. For Kinetic Spectrophotometric Method
20 tablets were weighed and triturated well. A quantity of powder equivalent to 50 mg of drug was transferred to 100 mL volumetric flask and mixed with 25 mL of double distilled water, and the solution was sonicated for 15 minutes. The volume was finally made up to 100 mL with double distilled water. The solution was filtered through Whatman filter paper no. 42. The filtrate was diluted with water to obtain working concentration in the range of 15–25 μg/mL for the drug.
2.3.1. Normal UV Method
Ten mL of stock solution A was taken and further diluted to 100 mL to obtain working stock solution of 100 μg/mL. From the solution, 2 mL was transferred to a ten mL volumetric flask, and the volume was made up to ten mL with double distilled water to get the final solution of 20 μg/mL. The solution was scanned between 400 nm and 200 nm. Wavelength of maximum absorbance () was found to be 261.40 nm. Different aliquots (0.2, 0.4,…,2.0 mL) of working stock solution were accurately measured and diluted in a series of ten mL volumetric flask with doubly distilled water to obtain concentrations of 1, 2, 3, 4,…, and 20 μg/mL.
2.3.2. Initial Rate Method
A series of dilutions (150–350 μg/mL) was prepared by pipetting out different aliquots of stock solution A into a series of 10 mL volumetric flask. At the time of observation, 1.6 mL of sodium hydroxide solution (1 M) was added, followed by 2.0 mL of potassium permanganate solution (0.006 M) to each flask and then diluted to the volume with double distilled water. The content of mixture of each flask was mixed well, and the increase in absorbance was recorded (in Kinetics mode) at 603.5 nm as a function of time for 15 minutes against reagent blank treated similarly. The initial rate of reaction at different concentrations was obtained from the slope of tangent to the absorbance time curve (at 5 minutes).
2.3.3. Fixed Time Method
In this method, the absorbance was recorded accurately at preselected time of 3, 6, 9, 12, and 15 minutes against reagent blank treated similarly. The calibration graphs were constructed by plotting the absorbances against various concentrations of the series of drug solution. The concentration of the drug was determined from either calibration curve or regression equation.
3. Results and Discussion
3.1. For Normal UV Method
3.2. Optimization of Parameters for Kinetic Spectrophotometric Method
Potassium permanganate, as strong oxidizing agent, has been used in oxidimetric analytical method for the determination of many compounds. The valency of manganese changes during the course of the reaction. The heptavalent manganese ion changes to the green color (Mn VI), while, in neutral and acidic medium, the permanganate is further reduced to colorless (Mn II). The behavior of permanganate was the basis for its use in the development of spectrophotometric method. The absorption spectrum of aqueous potassium permanganate solution in alkaline medium exhibited an absorption band at 526 nm. The addition of eperisone hydrochloride to this solution produces a new characteristic band at 603.5 nm. This is shown in Figure 4. The band is due to the formation of manganate ion, which resulted from the oxidation of eperisone hydrochloride by potassium permanganate in alkaline medium. The intensity of the color increases with time; therefore, a kinetically based method was successfully developed for the determination of eperisone hydrochloride in their pharmaceutical dosage formulations.
3.3. Effect of Potassium Permanganate Concentration
The absorbance increases substantially with increasing the concentration of potassium permanganate as shown in Figure 5. Maximum absorbance was obtained when 2.0 mL of 0.006 M of potassium permanganate was used. Thus, the adoption of 2 mL of potassium permanganate in the final solution proved to be adequate for the determination of eperisone hydrochloride (final concentration was 0.0012 M).
3.3.1. Effect of Sodium Hydroxide Concentration
Maximum absorption was obtained when 1.6 mL of 1 M NaOH was used. Over this volume, no deliberate change in absorbance could be detected. So, 1.6 mL of 1 M of NaOH was used as an optimum value as shown in Figure 6.
3.3.2. Effect of Temperature
At room temperature, the reaction rate increases substantially with time. Moreover, heating the solution was found to increase the rate of the reaction but caused precipitation of MnO2 also. Therefore, room temperature was selected as the optimum temperature.
The stoichiometric ratio between potassium permanganate and eperisone hydrochloride was determined by Job’s method and was found to be 4 : 1. Corrected Job’s plot is shown in Figure 7. Eperisone hydrochloride was found to be susceptible for oxidation with alkaline potassium permanganate producing a green color at of 603.5 nm.
3.3.4. Kinetics of the Reaction
Under the optimum conditions, the absorbance time curves of eperisone hydrochloride with potassium permanganate reagent were constructed (as shown in Figures 8 and 9). The initial rate of the reaction was determined from the slope of tangents of the absorption time curves. The order of the reaction with respect to permanganate was determined by studying the reaction at different concentrations of permanganate with fixed concentration of investigated eperisone hydrochloride. The plot of initial rate () against initial absorbance was linear passing through origin indicating that the initial order of the reaction with respect to permanganate was 1 as shown in Figure 10.
The order with respect to investigated eperisone hydrochloride was evaluated by measuring the rate of the reaction at several concentrations of eperisone hydrochloride at a fixed concentration of permanganate reagent as shown in Figure 11. This was done by plotting the logarithm of initial rate of the reaction versus logarithm of molar concentration of investigated eperisone hydrochloride and was found to be approximately 1 as shown in Figure 12. However, under the optimized experimental conditions, the concentrations of eperisone hydrochloride were determined using relative excess amount of potassium permanganate and sodium hydroxide solutions. Therefore, pseudo-zero-order conditions were obtained with respect to their concentrations.
3.3.5. Quantitation by Kinetic Methods
(1) Initial Rate Method. Initial rate of reaction would follow pseudo-first-order and were found to obey (1): where is the reaction rate, is absorbance, is the measuring time, is the pseudo-first-order rate constant, is the molar concentration, and is the order of the reaction. The logarithmic form of the reaction is shown in (2): Regression analysis was performed using the method of least square to evaluate the slopes, intercepts, and correlation coefficients. The analytical parameters and results of regression analysis are given in Table 2. The value of (≈1) in the regression equation confirmed that the reaction of eperisone hydrochloride with the potassium permanganate was a pseudo-first-order with respect to eperisone hydrochloride concentration. The limits of detection (LOD) were calculated, and results obtained confirmed good sensitivity of the proposed method and consequently their capabilities to determine low amount of eperisone hydrochloride.
(2) Fixed Time Method. In this method, the absorbance of the reaction solution containing varying amounts of eperisone HCl was measured at preselected fixed time. Calibration curve of absorbance versus the concentration of the drug at fixed time was plotted (shown in Figure 13). The regression equation, correlation coefficients, and detection limits were calculated and reported in Table 3. The lowest detection limit was obtained at fixed time of 6 minutes. However the fixed time of 3 minutes showed a wider concentration range for quantification.
Specificity of the UV method was evaluated by addition of common tablet excipients available in the laboratory and recording the UV scan. No interference was detected from the added excipients at 261.40 nm, and the variations in absorbance were negligible.
In case of kinetic spectroscopic method, both the proposed methods were performed in visible range away from the UV-absorption region. A very minor change in the absorbance values was seen during the time duration.
Accuracy studies in terms of percentage recovery (percentage) were studied for normal UV and kinetic spectroscopic method and reported in Tables 4, 5, and 6. The results of mean % recovery were within the range of 98–102%, and % RSD was less than 2% so the proposed method was found to be accurate.
3.4.5. Detection and Quantification Limits
4. Application of the Proposed Method
The developed methods were applied for the determination of eperisone HCl on pharmaceutical tablet dosage form. The tablet content was computed from its corresponding regression equations. The obtained mean recovery values of the labeled amounts were 100.4% ± 0.07, 99.93% ± 0.05, and 99.41% ± 0.04 as reported in Table 10.
The accuracy and precision of the kinetic methods (initial rate and fixed time) were statistically compared with that of UV spectrophotometric method. Statistical comparison was done by applying Student’s t-test and ANOVA. There was no significant difference found between the calculated and theoretical values at 95% confidence level as reported in Tables 11, 12, and 13. This indicated the similarities between the proposed and the reference method for the determination of eperisone HCl in the tablet dosage form.
In the present study, two spectroscopic methods (UV and kinetic spectroscopy) were developed, validated, and statistically compared for determining eperisone HCl in API as well as in tablet dosage forms. Normal UV method proved to be a simple and cost-effective method for the estimation of the drug. Kinetic spectroscopic method has been used in the past for the elemental analysis and detection of biomolecules in biological fluids (like enzymes). The applicability of this method has been successfully studied and extended in this research. The developed method involves measurements in the visible region and is more selective than the reported UV based methods. Further, the developed methods utilized doubly distilled water as solvent which is easily available, safe, and economical as well. The initial rate and fixed time methods can be easily applied as they do not require elaborate samples and/or tedious procedures for the analysis. Besides, both methods are sensitive enough for the analysis of lower amount of the drug. Furthermore, the developed methods do not require expensive instruments and/or critical analytical reagents. Statistical comparison of the two developed methods proved that there was no significant difference in the accuracy, precision, and quantitative capabilities. These advantages give the proposed methods a great value to the spectroscopic analysis of eperisone HCl in quality control laboratories.
Authors are thankful to Sun Pharma Industries, Mumbai, India, for providing gift sample in their research work.
- M. Sittig, Pharmaceutical Manufacturing Encyclopaedia, vol. 2, William Andrew Publishing, New York, NY, USA, 3rd edition, 2007.
- S. C. Sweetman, Martindale: The Complete Drug Reference, Pharmaceutical Press, London, UK, 36th edition, 2009.
- S. R. Crouch, T. F. Cullen, A. Scheeline, and E. S. Kirkor, “Kinetic determinations and some kinetic aspects of analytical chemistry,” Analytical Chemistry, vol. 70, no. 12, pp. 53R–106R, 1998.
- H. L. Pardue, “Kinetic aspects of analytical chemistry,” Analytica Chimica Acta, vol. 216, no. C, pp. 69–107, 1989.
- “Kinetic specroscopy,” http://www.asdlib.org/onlineArticles/ecourseware/Analytical%20Chemistry%202.0/Text_Files_files/Chapter13.pdf, 2012.
- B. Melilli, C. Piazza, D. C. Vitale et al., “Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 36, no. 2, pp. 71–78, 2011.
- T. Saito, T. Yamagiwa, Y. Yui et al., “Monolithic spin-column extraction and GC-MS method for the assay of eperisone in human serum,” Journal of Health Science, vol. 56, no. 5, pp. 598–605, 2010.
- L. Ding, X. Wang, Z. Yang, and Y. Chen, “The use of HPLC/MS, GC/MS, NMR, UV and IR to identify a degradation product of eperisone hydrochloride in the tablets,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 2, pp. 282–287, 2008.
- X. Wei, L. Ding, J. Gao et al., “Pharmacokinetics and bioequivalence of eperisone hydrochloride tablet in healthy subjects,” Yaoxue Xuebao, vol. 39, no. 4, pp. 309–311, 2004.
- T. Takamatsu, K. Yamazaki, M. Kayano, F. Takenaka, M. Hasui, and T. Ohkawa, “Determination of eperisone in human plasma by gas chromatography-mass spectrometry,” Journal of Chromatography, vol. 584, no. 2, pp. 261–266, 1992.
- G. Lunn, HPLC Methods for Recently Approved Pharmaceuticals, John Wiley & Sons, New Jersey, NJ, USA, 2005.
- Japanese Pharmacopoeia, Japanese Society of Pharmacopoeia, 15th edition, 2007.
- F. A. Skoog, F. J. Holler, and S. R. Crouch, “Introduction to UV spectroscopy,” in Principle of Instrumental Analysis, pp. 381–385, Brooks/Cole, Singapore, 6th edition, 2007.
- Z. D. Hill and P. MacCarthy, “Novel approach to job's method: an undergraduate experiment,” Journal of Chemical Education, vol. 63, no. 2, pp. 162–167, 1986.
- International Conference on Harmonization (ICH), “Validation of analytical procedures: text and methodology,” Harmonized tripartite guideline Q2(R1), 2005.
- United States Pharmacopeia 34 and National Formulary 29, General Chapter 1225, Validation of Compendial Procedures, vol. 1, United States Pharmacopeial Convention, Rockville, Md, USA, 2011.
- I. A. Khan and A. Khanum, Biostats for Pharmacy, Ukaaz, Hyderabad, India, 2nd edition, 2008.
- S. Bolton and C. Bon, Pharmaceutical Statistics: Practical and Clinical Application, Informa Healthcare, New York, NY, USA, 5th edition, 2009.